This webinar will review the regulatory requirements for investigating an OOS Investigation. The responsibilities of the analyst, the supervisor and QA will be discussed. A detailed flow chart will be used to help the attendees clearly understand the steps and the order in which they are to be performed. The structure of an Investigation report which properly documents the investigation will be discussed.
WHY SHOULD YOU ATTEND?
The lack of or Inadequate procedures for handling out of specification (OOS) situations and failure investigations are amongst the most frequently found deviations in FDA warning letters.
Most companies have procedures but either they are not adequate or are not followed. This seminar will guide attendees through the entire process from detection an out-of-specification result to informal and formal laboratory and batch investigations.
AREA COVERED
- Phase I- Laboratory Phase of Investigations
- Phase II a Full Scale Investigation
- Concluding an Investigation
- Out-of Trend investigations
- Common pitfalls during OOS Investigations
- Review of recent OOS related citations in Warning Letters
LEARNING OBJECTIVES
- Benefits: The lack of or Inadequate procedures for handling out of specification (OOS) situations and failure investigations are amongst the most frequently found deviations in FDA warning letters.
- Most companies have procedures but either they are not adequate or are not followed. This seminar will guide attendees through the entire process from detection an out-of-specification result to informal and formal laboratory and batch investigations.
- Complimentary Hand-outs (other than ppt slides): For e.g. checklists, process documents, flow charts, pdf or docs of supplementary reading material, etc.
WHO WILL BENEFIT?
- Quality Assurance/Quality Control Directors, Managers, and Specialists
- Regulatory Affairs/Regulatory Compliance Directors, Managers, and Specialists
- Quality Control Laboratory Staff
The lack of or Inadequate procedures for handling out of specification (OOS) situations and failure investigations are amongst the most frequently found deviations in FDA warning letters.
Most companies have procedures but either they are not adequate or are not followed. This seminar will guide attendees through the entire process from detection an out-of-specification result to informal and formal laboratory and batch investigations.
- Phase I- Laboratory Phase of Investigations
- Phase II a Full Scale Investigation
- Concluding an Investigation
- Out-of Trend investigations
- Common pitfalls during OOS Investigations
- Review of recent OOS related citations in Warning Letters
- Benefits: The lack of or Inadequate procedures for handling out of specification (OOS) situations and failure investigations are amongst the most frequently found deviations in FDA warning letters.
- Most companies have procedures but either they are not adequate or are not followed. This seminar will guide attendees through the entire process from detection an out-of-specification result to informal and formal laboratory and batch investigations.
- Complimentary Hand-outs (other than ppt slides): For e.g. checklists, process documents, flow charts, pdf or docs of supplementary reading material, etc.
- Quality Assurance/Quality Control Directors, Managers, and Specialists
- Regulatory Affairs/Regulatory Compliance Directors, Managers, and Specialists
- Quality Control Laboratory Staff
Speaker Profile
Danielle DeLucy, MS, is owner of ASA Training and Consulting, LLC which provides Pharmaceutical and Biologics based companies with training and quality systems assistance in order to meet Regulatory compliance. Prior to this role, Danielle has been in the industry for 15 years serving in numerous Quality Management Roles, such as the Director of Product Quality, the oversight of Sterility Assurance practices and provided QA oversight of numerous filling and packaging operations. Danielle began her QA career as a Quality Control Pharmaceutical Microbiologist at a contract laboratory where she performed various tests for their clients. In the years after, she …
Upcoming Webinars
Outlook - Master your Mailbox - Inbox Hero Inbox Zero
So, You’re Now the “Boss”: Essential Skills to Succeed as a…
FDA Compliance And Laboratory Computer System Validation
2-Hour Virtual Seminar on the 6 Most Common Problems in FDA…
Managing Toxic & Other Employees Who Have Attitude Issues
Harassment, Bullying, Gossip, Confrontational and Disruptiv…
Managing Complex Projects - Project Management
Tips and Techniques for Conducting an Effective Fraud Risk …
Design Verification, Validation and Testing for Medical Dev…
21 CFR Part 820 - Quality System Regulation - Applying Prin…
Performance Management: Dealing With The Difficult Employee
Treasury Risk Management, Funding, Liquidity, Interest Rate…
OSHA Requirements for Supervisors, Project Leaders & HR - W…
Future-Proof Your Workforce: Mastering Succession Planning …
California Meal and Rest Breaks: What You Don't Know Can Co…
HIPAA Bootcamp for Health Care Providers, Professionals, an…
Essential Job Functions According to the American with Disa…
Improving Employee Engagement & Retention Through Stay Inte…
FFIEC BSA/AML Examination Manual: What Compliance Officers …
Dealing With Difficult People In Life & Work
Introduction to Generative AI for Accountants
Conquer Toxic People - Learn To Protect Yourself And Get Yo…
Updated Metro 2®, e-OSCAR and the New Tougher FCRA/CFPB Com…
3-Hour Virtual Seminar on Excel Deep Dive: Advanced Tips & …
Impact Assessment and Risk Management for Change Control
How to Write Effective Audit Observations: The Principles f…
Surviving and Thriving Organizational Change and Loss: The …
Marijuana: Compliance and Safety in the Workplace
Coming Soon - New Minimum Salary Levels for Exempt Employee…
FDA Regulation of Artificial Intelligence/ Machine Learning
Stressed Out: How to Handle Conflict, Difficult People and …
Data Integrity: Compliance with 21 CFR Part 11, SaaS-Cloud,…
2025 Top Employment Regulations That Will Impact Employers!
How to Handle Workplace Conversations Around Politics and R…
Why EBITDA Doesn't Spell Cash Flow and What Does
How to Give Corrective Feedback: The CARE Model - Eliminati…
SOPs - How to Write Them to Satisfy those Inspectors
Documenting Misconduct that Will Stand Up in Court
With Mandatory Paid Leave Gaining Ground Is It Time To Do A…
Marketing to Medicare or Medicaid Beneficiaries - What You …
Trial Master File (TMF)/eTMF, & FDAs Draft Guidance for Ele…
Project Management for Non-Project Managers - How to commun…
Tattoos, hijabs, piercings, and pink hair: The challenges …
Human Error Reduction Techniques for Floor Supervisors
Onboarding is NOT Orientation - How to Improve the New Empl…
Building GMP Excellence: A Guide to Implementing Compliant …